Status:
UNKNOWN
The Effect of Intravenous Nalbuphine on PONV With Intrathecal Morphine in Abdominoplasty.
Lead Sponsor:
Assiut University
Conditions:
Abdominal Obesity
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
How effectively intravenous nalbuphine can reduce the incidence of PONV after intrathecal administration of morphine in abdominoplastic surgery.
Eligibility Criteria
Inclusion
- Patients undergoing abdominoplasty under spinal anesthesia
- American Society of Anesthesiologists (ASA) class I and II.
Exclusion
- allergy to local anesthetics
- bleeding diatheses
- local infection or sepsis
Key Trial Info
Start Date :
March 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03786562
Start Date
March 8 2019
End Date
September 1 2020
Last Update
March 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt